EMA conference: "Regulatory science: are regulators leaders or followers?"
Event
Date
Location
The conference highlighted a range of scientific topics including the role the Agency can play to best support regulatory sciences. Topics included models to support benefit-risk assessment, the challenges associated with regulation of biotechnological medicinal products, addressing the efficacy-effectiveness gap of medicines, the appropriate use of health data to support medicines regulation, ongoing efforts to detect safety issues, and novel statistical methodologies for clinical trials.